Nanomedical Diagnostics Announces Peer-Reviewed Publication…


AGILE R100 Label-Free Assay System

AGILE R100 is a viable, even preferable alternative to SPR or BLI tools, as it uses less reagents and time to obtain data while providing a more efficient user experience.

Nanomedical Diagnostics, a biotech company driving the use of label-free graphene biosensor assays in life science research and diagnostics, announces a publication co-authored by researchers from UC San Diego and UC Irvine titled “Large Scale Commercial Fabrication of High Quality Graphene-Based Assays for Biomolecule Detection” in the journal Sensors & Actuators B: Chemical (Lerner 2016). The paper describes the company’s…



Read the full article from the Source…

Back to Top